VANCOUVER, British Columbia--(BUSINESS WIRE)--July 10, 2006--MIV Therapeutics (OTCBB:MIVT - News; FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, will host an investor conference call tomorrow, Tuesday, July 11, 2006, at 12:00 PM Eastern, to discuss a growing body of evidence that validates the Company’s innovative program to make a safer generation of coronary stents based on its unique, bio-friendly coating technologies.
